Hood River Capital Management LLC Moon Lake Immunotherapeutics Transaction History
Hood River Capital Management LLC
- $5.4 Billion
- Q3 2024
A detailed history of Hood River Capital Management LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Hood River Capital Management LLC holds 646,662 shares of MLTX stock, worth $28.3 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
646,662Holding current value
$28.3 Million% of portfolio
0.6%Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
125Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$953 Million34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$372 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$131 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$121 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$102 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.62B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...